Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Plos Pathogens|October 10, 2024
Humoral and T-cell-mediated responses to an insect-specific flavivirus-based Zika virus vaccine candidateDanielle L Porier, Awadalkareem Adam, Lin Kang, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
A safe insect-based Chikungunya fever vaccine affords rapid and durable protection in cynomolgus macaquesAwadalkareem Adam, Courtney Woolsey, Hannah Lu, et al.
NPJ Vaccines|December 20, 2024
A safe insect-based chikungunya fever vaccine affords rapid and durable protection in cynomolgus macaquesAwadalkareem Adam, Courtney Woolsey, Hannah Lu, et al.
Journal of Virology|January 7, 2026
mRNA-delivered neutralizing antibodies confer protection against SARS-CoV-2 in animal modelsNicholas C Hazell, Rachel A Reyna, Awadalkareem Adam, et al.
Emerging Microbes & Infections|February 4, 2021
Optimized production and immunogenicity of an insect virus-based chikungunya virus candidate vaccine in cell culture and animal modelsAwadalkareem Adam, Huanle Luo, Samantha R Osman, et al.
NPJ Vaccines|December 10, 2019
An attenuated Zika virus NS4B protein mutant is a potent inducer of antiviral immune responsesGuangyu Li, Awadalkareem Adam, Huanle Luo, et al.
NPJ Vaccines|November 30, 2021
Mucosal vaccination induces protection against SARS-CoV-2 in the absence of detectable neutralizing antibodiesChaojie Zhong, Hongjie Xia, Awadalkareem Adam, et al.
NPJ Vaccines|February 18, 2021
A genetically stable Zika virus vaccine candidate protects mice against virus infection and vertical transmissionAwadalkareem Adam, Camila R Fontes-Garfias, Vanessa V Sarathy, et al.
Journal of Medical Virology|March 26, 2026
Variant-Specific tRNA-Derived Fragments Induced By Severe Acute Respiratory Syndrome Coronavirus 2: Implications for Disease Outcome DifferentiationWenzhe Wu, Meagan D Rippee-Brooks, Awadalkareem Adam, et al.
Science Translational Medicine|September 14, 2022
Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical modelsRenee L Hajnik, Jessica A Plante, Yuejin Liang, et al.
Pageof 5